[fa icon="calendar'] October 31, 2014 / posted in Interventional Cardiology
Washington, DC—Conversations about the future of renal denervation for systemic hypertension and carotid artery stenting (CAS), as well as the place for expensive technologies in treating long superficial femoral artery (SFA) occlusions took center stage at the “Endov
[fa icon="calendar'] August 7, 2007 / posted in Dr. Mark Bates, Interventional Cardiology, Nanotech, Carbon nanotube technology, Unidym
Pasadena, CA & Charleston, WV - Arrowhead Research Corporation and Paragon Intellectual Properties, LCC announced recently that Arrowhead's majority-owned subsidiary, Unidym Inc., has signed an exclusive license agreement with Paragon's majority-owned subsidiary, Nanot
[fa icon="calendar'] February 2, 2007 / posted in Dr. Mark Bates, Interventional Cardiology
Finding specialized care at the CAMC Vascular Center of Excellence
Peripheral arterial disease affects 8 to 12 million people in the United States. There are many people in West Virginia who suffer from this, as well as many other conditions associated with vascular di
Nexeon is a bioelectronics company developing and manufacturing medical devices and the software platforms that support the remote management of these devices.
[fa icon="phone"]
[fa icon="envelope"] [email protected]
[fa icon="home"] 1708 Jaggie Fox Way, Lexington KY 40511